About-face on the metabolic side effects of rapamycin

Oncotarget. 2015 Feb 20;6(5):2585-6. doi: 10.18632/oncotarget.3354.

Author

Adam B Salmon¹

Affiliation

¹ The Sam and Ann Barshop Institute for Longevity and Aging Studies and Department of Molecular Medicine, The University of Texas Health Science Center at San Antonio and Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX, USA.

No abstract available

Publication types

Editorial

MeSH terms

Animals
Blood Glucose / drug effects
Blood Glucose / metabolism
Energy Metabolism / drug effects*
Humans
Insulin / blood
Longevity / drug effects
Protein Kinase Inhibitors / adverse effects*
Sirolimus / adverse effects*
TOR Serine-Threonine Kinases / antagonists & inhibitors*
TOR Serine-Threonine Kinases / metabolism

Substances

Blood Glucose
Insulin
Protein Kinase Inhibitors
TOR Serine-Threonine Kinases
Sirolimus